Article info

Download PDFPDF

Hypothesis: does adrenalitis caused by immune checkpoint-inhibitors put melanoma patients at an elevated risk for recurrence?

Authors

  • Igor Alexander Harsch Department of Internal Medicine II, Division of Endocrinology and MetabolismThuringia Clinic Saalfeld “Georgius Agricola” Rainweg 68 07318 Saalfeld/Saale Germany PubMed articlesGoogle scholar articles
  1. a +49(0)3671 541569 iharsch{at}thueringen-kliniken.de
View Full Text

Citation

Harsch IA
Hypothesis: does adrenalitis caused by immune checkpoint-inhibitors put melanoma patients at an elevated risk for recurrence?

Publication history

  • Received March 28, 2019
  • Accepted June 21, 2019
  • First published July 4, 2019.
Online issue publication 
July 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.